146 related articles for article (PubMed ID: 8230108)
1. Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity.
Johnson RA; Gorman RR; Wnuk RJ; Crittenden NJ; Aiken JW
J Med Chem; 1993 Oct; 36(21):3202-6. PubMed ID: 8230108
[TBL] [Abstract][Full Text] [Related]
2. A turn-off fluorescence probe based on terpyridine for pH monitoring.
Zhuge X; Li J; Li Y; Yuan C
Luminescence; 2020 May; 35(3):373-378. PubMed ID: 31858706
[TBL] [Abstract][Full Text] [Related]
3. General protocols for the synthesis of C(2)-symmetric and asymmetric 2,8-disubstituted analogues of Tröger's base via efficient bromine-lithium exchanges of 2,8-dibromo-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine.
Jensen J; Tejler J; Wärnmark K
J Org Chem; 2002 Aug; 67(17):6008-14. PubMed ID: 12182636
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Tröger's base analogues as selective inhibitors against human breast cancer cell line: design, synthesis and cytotoxic evaluation.
Manda BR; Alla M; Ganji RJ; Addlagatta A
Eur J Med Chem; 2014 Oct; 86():39-47. PubMed ID: 25140752
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of Tröger's base formation probed by electrospray ionization mass spectrometry.
Abella CA; Benassi M; Santos LS; Eberlin MN; Coelho F
J Org Chem; 2007 May; 72(11):4048-54. PubMed ID: 17472399
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical and nonsymmetrical chromophores with Tröger's base skeleton: chiroptical, linear, and quadratic nonlinear optical properties--a joint theoretical and experimental study.
Sergeyev S; Didier D; Boitsov V; Teshome A; Asselberghs I; Clays K; Vande Velde CM; Plaquet A; Champagne B
Chemistry; 2010 Jul; 16(27):8181-90. PubMed ID: 20533454
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Antibacterial Activity of Spiro[4
Liu RX; Liang YN; Ren XX; Wu QQ; Huang C; Cao SN; Wan Y; Zhou SL; Yuan R; Wu H
Curr Org Synth; 2023; 20(8):870-879. PubMed ID: 35702794
[TBL] [Abstract][Full Text] [Related]
8. 1-Imidazolylcarbonyloxy-substituted tetrahydroquinolines and pyridines: synthesis and evaluation of P450 TxA2 inhibition.
Hartmann RW; Frotscher M
Arch Pharm (Weinheim); 1999 Oct; 332(10):358-62. PubMed ID: 10575369
[TBL] [Abstract][Full Text] [Related]
9. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a novel N-F reagent derived from the ethano-Tröger's base: (1)J(FN) coupling constants as a signature for the N-F bond.
Pereira R; Wolstenhulme J; Sandford G; Claridge TD; Gouverneur V; Cvengroš J
Chem Commun (Camb); 2016 Jan; 52(8):1606-9. PubMed ID: 26658721
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of a Novel Banana-Shaped Functional Molecule via Double Cross-Coupling.
Yang B; Shen G; Huang X; Liu R
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769955
[TBL] [Abstract][Full Text] [Related]
12. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.
Johnson RA; Nidy EG; Aiken JW; Crittenden NJ; Gorman RR
J Med Chem; 1986 Aug; 29(8):1461-8. PubMed ID: 3735314
[TBL] [Abstract][Full Text] [Related]
14. A Protocol for the exo-Mono and exo,exo-Bis Functionalization of the Diazocine Ring of Tröger's Base.
Dawaigher S; Månsson K; Ascic E; Artacho J; Mårtensson R; Loganathan N; Wendt OF; Harmata M; Snieckus V; Wärnmark K
J Org Chem; 2015 Dec; 80(24):12006-14. PubMed ID: 26597045
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridylalkenoic acids.
Kato K; Ohkawa S; Terao S; Terashita Z; Nishikawa K
J Med Chem; 1985 Mar; 28(3):287-94. PubMed ID: 4038746
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a novel dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase (E3040) via the direct coupling reaction of hydroquinone with 3-pyridinecarboxaldehyde.
Komatsu Y; Minami N
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1614-6. PubMed ID: 8536337
[TBL] [Abstract][Full Text] [Related]
17. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Characterization of Metalloporphyrin Tröger's and Spiro-Tröger's Base Derivatives.
Navrátilová T; Tatar A; Havlík M; Hajduch J; Drozdová M; Gurung K; Palatinus L; Čejka J; Sedláček J; Anzenbacher P; Dolenský B
J Org Chem; 2022 Nov; 87(22):15178-15186. PubMed ID: 36327130
[TBL] [Abstract][Full Text] [Related]
19. Optically active Ru(II) complexes with a chiral Tröger's base ligand and their interactions with DNA.
Claessens N; Pierard F; Bresson C; Moucheron C; Kirsch-De Mesmaeker A
J Inorg Biochem; 2007 Jul; 101(7):987-96. PubMed ID: 17499361
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
